{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.19"}]}],"title":"Highest % of CD8 cells Pre-vaccine"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.94"}]}],"title":"Best Response % of CD8 cells Day +30"}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"description":"Best CD8+ response against CRM197 at day +30 for CD107a. Peripheral Blood Mononuclear Cells (PBMCs) were incubated with CRM197, or control. Cells were harvested and stained for flow cytometry.","groups":[{"description":"Pneumococcal conjugate vaccine (PCV 13), 0.5ml, 3 to 30 days prior to transplant and then again at 7-10 and 21-24 days after transplant.","id":"OG000","title":"Experimental: PCV 13"}],"paramType":"NUMBER","populationDescription":"All evaluable participants.","reportingStatus":"POSTED","timeFrame":"30 Days Post Vaccine","title":"CD8+CD107a+, Best Response Against Vaccine (CRM 197)","type":"SECONDARY","unitOfMeasure":"percentage of CD8 cells"}